Persistent infection with neurotropic herpes viruses and cognitive impairment

Psychological Medicine

Volumn 43, Issue 5, 2013, Pages 1023-1031

  Watson, A M M ^a   Prasad, K M ^a   Klei, L ^a   Wood, J A ^a   Yolken, R H ^b   Gur, R C ^c,d   Bradford, L D ^e   Calkins, M E ^c   Richard, J ^c   Edwards, N ^f   Savage, R M ^g   Allen, T B ^h   Kwentus, J ⁱ   McEvoy, J P ^h   Santos, A B ^j   Wiener, H W ^k   Go, R C P ^k   Perry, R T ^k   Nasrallah, H A ^l   Gur, R E ^c   Devlin, B ^a   Nimgaonkar, V L ^a   more..

^a UNIVERSITY OF PITTSBURGH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e MOREHOUSE SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h DUKE UNIVERSITY MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^j MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^k UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^l UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

more..

Author keywords

Cognition; cytomegalovirus; HSV 1; HSV 2; schizophrenia

Indexed keywords

VIRUS ANTIBODY;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD; BRAIN; CASE CONTROL STUDY; CHRONIC DISEASE; COGNITIVE DEFECT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; GENETIC PREDISPOSITION; GENETICS; HERPES SIMPLEX; HUMAN; IMMUNOLOGY; MALE; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TEST; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PSYCHOLOGICAL ASPECT; SCHIZOPHRENIA; SIMPLEXVIRUS; STATISTICAL MODEL; STATISTICS; VIROLOGY;

ADULT; AFRICAN AMERICANS; ANTIBODIES, VIRAL; BRAIN; CASE-CONTROL STUDIES; CHRONIC DISEASE; COGNITION DISORDERS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HERPES SIMPLEX; HUMANS; MALE; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; SCHIZOPHRENIA; SIMPLEXVIRUS;

EID: 84875950697     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S003329171200195X     Document Type: Article

References (45)

1. Aiello AE, Haan M, Blythe L, Moore K, Gonzalez JM, Jagust W (2006). The influence of latent viral infection on rate of cognitive decline over 4 years. Journal of the American Geriatrics Society 54, 1046-1054.
2. Aliyu MH, Calkins ME, Swanson Jr. CL, Lyons PD, Savage RM, May R, Wiener H, McLeod-Bryant S, Nimgaonkar VL, Ragland JD, Gur RE, Gur RC, Bradford LD, Edwards N, Kwentus J, McEvoy JP, Santos AB, McCleod-Bryant S, Tennison C, Go RC, Allen TB (2006). Project among African-Americans to explore risks for schizophrenia (PAARTNERS): recruitment and assessment methods. Schizophrenia Research 87, 32-44.
3. Almasy L, Blangero J (1998). Multipoint quantitative-trait linkage analysis in general pedigrees. American Journal of Human Genetics 62, 1198-1211.
4. Alvarez G, Aldudo J, Alonso M, Santana S, Valdivieso F (2012). Herpes simplex virus type 1 induces nuclear accumulation of hyperphosphorylated tau in neuronal cells. Journal of Neuroscience Research 90, 1020-1029.
5. Baringer JR, Pisani P (1994). Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Annals of Neurology 36, 823-829.
6. Bertrand P, Guillaume D, Hellauer K, Dea D, Lindsay J, Kogan S, Gauthier S, Poirier J (1993). Distribution of herpes simplex virus type 1 DNA in selected areas of normal and Alzheimer's disease brains: a PCR study. Neurodegeneration 2, 201-208.
7. Borgo F, Sgaramella TM, Penello B, L'Erario R, Toso V (2000). A componential analysis of visual object recognition deficits in patients with herpes simplex virus encephalitis. Brain and Cognition 43, 53-56.
8. Brown AS, Derkits EJ (2010). Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. American Journal of Psychiatry 167, 261-280.
9. Buursma AR, de Vries EF, Garssen J, Kegler D, van Waarde A, Schirm J, Hospers GA, Mulder NH, Vaalburg W, Klein HC (2005). [18F]FHPG positron emission tomography for detection of herpes simplex virus (HSV) in experimental HSV encephalitis. Journal of Virology 79, 7721-7727.
10. Calkins ME, Tepper P, Gur RC, Ragland JD, Klei L, Wiener HW, Richard J, Savage RM, Allen TB, O'Jile J, Devlin B, Kwentus J, Aliyu MH, Bradford LD, Edwards N, Lyons PD, Nimgaonkar VL, Santos AB, Go RC, Gur RE (2010). Project among African-Americans to explore risks for schizophrenia (PAARTNERS): evidence for impairment and heritability of neurocognitive functioning in families of schizophrenia patients. American Journal of Psychiatry 167, 459-472.
11. Carter C (2011). Alzheimer's disease: APP, gamma secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and their relationships with herpes simplex, C. pneumoniae, other suspect pathogens, and the immune system. International Journal of Alzheimer's Disease. Published online: 29 December 2011, doi:10.4061/2011/501862.
12. Cheeran MC, Lokensgard JR, Schleiss MR (2009). Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clinical Microbiology Reviews 22, 99-126.
13. Delisi LE, Smith SB, Hamovit JR, Maxwell ME, Goldin LR, Dingman CW, Gershon ES (1986). Herpes simplex virus, cytomegalovirus and Epstein-Barr virus antibody titres in sera from schizophrenic patients. Psychological Medicine 16, 757-763.
14. Dickerson F, Stallings C, Sullens A, Origoni A, Leister F, Krivogorsky B, Yolken R (2008). Association between cognitive functioning, exposure to Herpes Simplex Virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder. Brain, Behavior, and Immunity 22, 1103-1107.
15. Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Cole S, Krivogorsky B, Yolken RH (2004). Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder. Biological Psychiatry 55, 588-593.
16. Dickerson FB, Boronow JJ, Stallings C, Origoni AE, Ruslanova I, Yolken RH (2003). Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia. Archives of General Psychiatry 60, 466-472.
17. Féart C, Helmer C, Fleury H, Béjot Y, Ritchie K, Amouyel P, Schraen-Maschke S, Buée L, Lambert JC, Letenneur L, Dartigues JF (2011). Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels. PLoS ONE 6, e29480.
18. Goodkin ML, Morton ER, Blaho JA (2004). Herpes simplex virus infection and apoptosis. International Reviews of Immunology 23, 141-172.
19. Gur RC, Ragland JD, Moberg PJ, Turner TH, Bilker WB, Kohler C, Siegel SJ, Gur RE (2001). Computerized neurocognitive scanning: I. Methodology and validation in healthy people. Neuropsychopharmacology 25, 766-776.
20. Gur RE, Nimgaonkar VL, Almasy L, Calkins ME, Ragland JD, Pogue-Geile MF, Kanes S, Blangero J, Gur RC (2007). Neurocognitive endophenotypes in a multiplex multigenerational family study of schizophrenia. American Journal of Psychiatry 164, 813-819.
21. Itzhaki R (2004). Herpes simplex virus type 1, apolipoprotein E and Alzheimer's disease. Herpes 11 (Suppl. 2), 77A-82A.
22. Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF (1991). Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. Journal of Medical Virology 33, 224-227.
23. Kaufman HE, Azcuy AM, Varnell ED, Sloop GD, Thompson HW, Hill JM (2005). HSV-1 DNA in tears and saliva of normal adults. Investigative Ophthalmology and Visual Science 46, 241-247.
24. Klei L, Luca D, Devlin B, Roeder K (2008). Pleiotropy and principal components of heritability combine to increase power for association analysis. Genetic Epidemiology 32, 9-19.
25. Licastro F, Carbone I, Ianni M, Porcellini E (2011). Gene signature in Alzheimer's disease and environmental factors: the virus chronicle. Journal of Alzheimer's Disease 27, 809-817.
26. McGrath N, Anderson NE, Croxson MC, Powell KF (1997). Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. Journal of Neurology, Neurosurgery, and Psychiatry 63, 321-326.
27. McKenna DB, Neill WA, Norval M (2001). Herpes simplex virus-specific immune responses in subjects with frequent and infrequent orofacial recrudescences. British Journal of Dermatology 144, 459-464.
28. Ott J, Rabinowitz D (1999). A principal-components approach based on heritability for combining phenotype information. Human Heredity 49, 106-111.
29. Prasad KM, Shirts BH, Yolken RH, Keshavan MS, Nimgaonkar VL (2007). Brain morphological changes associated with exposure to HSV1 in first-episode schizophrenia. Molecular Psychiatry 12, 105-113.
30. Prasad KM, Watson AM, Dickerson FB, Yolken RH, Nimgaonkar VL (2012). Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia. Schizophrenia Bulletin. Published online: 6 April 2012. doi:10.1093/schbul/sbs046.
31. Schmutzhard E (2001). Viral infections of the CNS with special emphasis on herpes simplex infections. Journal of Neurology 248, 469-477.
32. Schretlen DJ, Vannorsdall TD, Winicki JM, Mushtaq Y, Hikida T, Sawa A, Yolken RH, Dickerson FB, Cascella NG (2010). Neuroanatomic and cognitive abnormalities related to herpes simplex virus type 1 in schizophrenia. Schizophrenia Research 118, 224-231.
33. Shirts BH, Prasad KM, Pogue-Geile MF, Dickerson F, Yolken RH, Nimgaonkar VL (2008). Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia. Schizophrenia Research 106, 268-274.
34. Smith JS, Robinson NJ (2002). Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. Journal of Infectious Diseases 186, S3-S28.
35. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ (2006). Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clinical Infectious Diseases 43, 1143-1151.
36. Steiner I, Kennedy PG, Pachner AR (2007). The neurotropic herpes viruses: herpes simplex and varicella-zoster. Lancet Neurology 6, 1015-1028.
37. Stevens JG, Haarr L, Porter DD, Cook ML, Wagner EK (1988). Prominence of the herpes simplex virus latency-associated transcript in trigeminal ganglia from seropositive humans. Journal of Infectious Diseases 158, 117-123.
38. Strandberg TE, Pitkala K, Eerola J, Tilvis R, Tienari PJ (2005). Interaction of herpesviridae, APOE gene, and education in cognitive impairment. Neurobiology of Aging 26, 1001-1004.
39. Strandberg TE, Pitkala KH, Linnavuori KH, Tilvis RS (2003). Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases. Stroke 34, 2126-2131.
40. Taylor GH (2003). Cytomegalovirus. American Family Physician 67, 519-524.
41. Toulopoulou T, Goldberg TE, Mesa IR, Picchioni M, Rijsdijk F, Stahl D, Cherny SS, Sham P, Faraone SV, Tsuang M, Weinberger DR, Seidman LJ, Murray RM (2010). Impaired intellect and memory: a missing link between genetic risk and schizophrenia? Archives of General Psychiatry 67, 905-913.
42. Whitley RJ (1996). Herpesviruses. In: Medical Microbiology 4th edn [e-book] (ed. S. Baron), chapter 68. Galveston (TX): University of Texas Medical Branch at Galveston (http://www.ncbi.nlm.nih.gov/books/NBK8157/).
43. Wiener H, Klei L, Calkins M, Wood J, Nimgaonkar V, Gur R, Bradford LD, Richard J, Edwards N, Savage R, Kwentus J, Allen T, McEvoy J, Santos A, Devlin B, Go R (2012). Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects. Schizophrenia Bulletin. Published online 10 January 2012. doi:10.1093/schbul/sbr161V.
44. Wiener HW, Klei L, Irvin MD, Perry RT, Aliyu MH, Allen TB, Bradford LD, Calkins ME, Devlin B, Edwards N, Gur RE, Gur RC, Kwentus J, Lyons PD, McEvoy JP, Nasrallah HA, Nimgaonkar VL, O'Jile J, Santos AB, Savage RM, Go RC (2009). Linkage analysis of schizophrenia in African-American families. Schizophrenia Research 109, 70-79.
45. Zeger SL, Liang KY (1986). Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42, 121-130.